ELITE PHARMACEUTICALS INC COM NEW ELTP
COM · Common Stock · CUSIP 28659T200
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNorthvale, NJ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 1.0bn as of 2022-06-23, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.04.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 2 |
| Q1 2021 | 2 |
| Q2 2021 | 2 |
| Q3 2021 | 1 |
| Q4 2021 | 3 |
| Q1 2022 | 3 |
| Q2 2022 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 0 | 0 |
| Q4 2020 | 1 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 1 |
| Q4 2021 | 1 | 0 |
| Q1 2022 | 1 | 1 |
| Q2 2022 | 1 | 1 |
Biggest buyers
| Blackston Financial Advisory Group, LLC | Added | +238.3k |
Biggest sellers
| IFP Advisors, Inc | Sold out | -200.8k |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Blackston Financial Advisory Group, LLC 0.02% of their portfolio | 577.6k $25.0k | Added +238.3k |
| Fisher Asset Management, LLC 0.00% of their portfolio | 82.0k $4.0k | Unchanged |